Tech Company Financing Transactions
Orakl Oncology Funding Round
Singular, Bpifrance and private investors participated in a $11.5 million Seed funding round for Orakl Oncology. The funding round was announced on 12/3/2024.
Transaction Overview
Company Name
Announced On
12/3/2024
Transaction Type
Venture Equity
Amount
$11,500,000
Round
Seed
Proceeds Purpose
This capital will be used to accelerate the company's growth and support the launch of two new commercial products, O-Predict and O-Validate.
Company Information
Company Status
Private & Independent
Industry
Artificial Intelligence
Mailing Address
63 rue Gabriel Peri
Le Kremlin Bicêtre, 94270
France
Le Kremlin Bicêtre, 94270
France
Phone
Undisclosed
Website
Email Address
Overview
We are on a mission to accelerate drug discovery in oncology; Orakl Oncology partners with the oncology industry to meet the challenge of personalized medicine.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Fanny Jaulin
Chief Operating Officer
Diane-Laure Pagès
Chief Technical Officer
Gustave Ronteix
Browse more venture capital transactions:
Prev: 12/3/2024: Recall venture capital transaction
Next: 12/3/2024: R2 venture capital transaction
Share this article
Where The Data Comes From
We do our best to record tech company VC transactions. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs